Cargando…

Pharmacokinetics, Pharmacodynamics, and Safety of Nivolumab in Patients With Sepsis-Induced Immunosuppression: A Multicenter, Open-Label Phase 1/2 Study

BACKGROUND: Sepsis often induces an immunosuppressive state, which is associated with high mortality rates. Immunostimulation may be beneficial for sepsis. We investigated the pharmacokinetics, pharmacodynamics, and safety of nivolumab, a human programmed death-1 immune checkpoint inhibitor approved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Watanabe, Eizo, Nishida, Osamu, Kakihana, Yasuyuki, Odani, Motoi, Okamura, Tatsuaki, Harada, Tomohiro, Oda, Shigeto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Clinical Science Aspects
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7448837/ https://www.ncbi.nlm.nih.gov/pubmed/31513050 http://dx.doi.org/10.1097/SHK.0000000000001443

Ejemplares similares

LOW DOSE OF ESMOLOL ATTENUATES SEPSIS-INDUCED IMMUNOSUPPRESSION VIA MODULATING T-LYMPHOCYTE APOPTOSIS AND DIFFERENTIATION
por: Ma, Ying, et al.
Publicado: (2023)

A PREDICTION MODEL FOR SEPSIS IN INFECTED PATIENTS: EARLY ASSESSMENT OF SEPSIS ENGAGEMENT
por: Guo, Siying, et al.
Publicado: (2023)

Comparison of the Performance Between Sepsis-1 and Sepsis-3 in ICUs in China: A Retrospective Multicenter Study
por: Cheng, Baoli, et al.
Publicado: (2017)

INVESTIGATION INTO P2Y RECEPTOR FUNCTION IN PLATELETS FROM PATIENTS WITH SEPSIS
por: Arkless, Kate L., et al.
Publicado: (2023)

Impact of Platelet Transfusion Thresholds on Outcomes of Patients With Sepsis: Analysis of the MIMIC-IV Database
por: Zhou, Wei, et al.
Publicado: (2022)

Blood Lactate Levels Cutoff and Mortality Prediction in Sepsis—Time for a Reappraisal? a Retrospective Cohort Study
por: Filho, Roberto Rabello, et al.
Publicado: (2016)

Immunoadjuvant therapy in sepsis: novel strategies for immunosuppressive sepsis coming down the pike
por: Watanabe, Eizo, et al.
Publicado: (2018)

A MODIFIED SURGICAL SEPSIS MODEL SATISFYING SEPSIS-3 AND HAVING HIGH CONSISTENCY OF MORTALITY
por: Wang, Jiebo, et al.
Publicado: (2023)

Pharmacokinetic/pharmacodynamic variations during sepsis/septic shock
por: Bakdach, Dana
Publicado: (2019)

Recombinant Human-Soluble Thrombomodulin Contributes to Reduced Mortality in Sepsis Patients With Severe Respiratory Failure: A Retrospective Observational Study Using a Multicenter Dataset
por: Yoshihiro, Shodai, et al.
Publicado: (2019)

THE ROLE OF OBESITY AND PLASMA ADIPOCYTOKINES IN IMMUNE DYSREGULATION IN SEPSIS PATIENTS
por: de Nooijer, Aline H., et al.
Publicado: (2023)

CLINICAL PHENOTYPES OF SEPSIS-ASSOCIATED ENCEPHALOPATHY: A RETROSPECTIVE COHORT STUDY
por: Lu, Xin, et al.
Publicado: (2023)

SUPPLEMENTATION WITH NICOTINAMIDE RIBOSIDE ATTENUATES T CELL EXHAUSTION AND IMPROVES SURVIVAL IN SEPSIS
por: Zhao, Guang-ju, et al.
Publicado: (2023)

Intracranial antitumor responses of nivolumab and ipilimumab: a pharmacodynamic and pharmacokinetic perspective, a scoping systematic review
por: van Bussel, Mark T. J., et al.
Publicado: (2019)

Full Activation of CD4(+) T Cells Early During Sepsis Requires Specific Antigen
por: Schmoeckel, Katrin, et al.
Publicado: (2015)

Organ-Specific Differences in Endothelial Permeability-Regulating Molecular Responses in Mouse and Human Sepsis
por: Aslan, Adnan, et al.
Publicado: (2017)

Proenkephalin Compared to Conventional Methods to Assess Kidney Function in Critically Ill Sepsis Patients
por: Beunders, Remi, et al.
Publicado: (2020)

The 28-Day Mortality Outcome of the Complete Hour-1 Sepsis Bundle in the Emergency Department
por: Prachanukool, Thidathit, et al.
Publicado: (2021)

Omeprazole Increases Survival Through the Inhibition of Inflammatory Mediaters in Two Rat Sepsis Models
por: Kotsuka, Masaya, et al.
Publicado: (2022)

DIAGNOSTIC ACCURACY AND ADDED VALUE OF INFECTION BIOMARKERS IN PATIENTS WITH POSSIBLE SEPSIS IN THE EMERGENCY DEPARTMENT
por: Christensen, Erik E., et al.
Publicado: (2022)

HIGH-MOLECULAR-WEIGHT HYALURONAN—A POTENTIAL ADJUVANT TO FLUID RESUSCITATION IN ABDOMINAL SEPSIS?
por: Barrueta Tenhunen, Annelie, et al.
Publicado: (2023)

Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department Patients with Sepsis
por: Hou, Peter C., et al.
Publicado: (2016)

The Diagnostic and Prognostic Value of suPAR in Patients with Sepsis: A Systematic Review and Meta-Analysis
por: Huang, Qiangru, et al.
Publicado: (2020)

Pyruvate-Driven Oxidative Phosphorylation is Downregulated in Sepsis-Induced Cardiomyopathy: A Study of Mitochondrial Proteome
por: Shimada, Briana K., et al.
Publicado: (2022)

EARLY DIFFERENTIATION BETWEEN SEPSIS AND STERILE INFLAMMATION VIA URINARY GENE SIGNATURES OF METABOLIC DYSREGULATION
por: Bandyopadhyay, Sabyasachi, et al.
Publicado: (2022)

Enhanced Expression of Cell-Specific Surface Antigens on Endothelial Microparticles in Sepsis-Induced Disseminated Intravascular Coagulation
por: Matsumoto, Hisatake, et al.
Publicado: (2015)

sEH Inhibitor Tppu Ameliorates Cecal Ligation and Puncture-Induced Sepsis by Regulating Macrophage Functions
por: Chen, Zhihui, et al.
Publicado: (2020)

Prognosis and Risk Factors of Sepsis Patients in Chinese ICUs: A Retrospective Analysis of a Cohort Database
por: Qu, Zeyu, et al.
Publicado: (2021)

SCREENING OF POTENTIAL CORE GENES IN PERIPHERAL BLOOD OF ADULT PATIENTS WITH SEPSIS BASED ON TRANSCRIPTION REGULATION FUNCTION
por: Liu, Jitao, et al.
Publicado: (2023)

CHARACTERISTICS AND PREDICTORS OF PATIENTS WITH SEPSIS WHO ARE CANDIDATES FOR MINIMALLY INVASIVE APPROACH OUTSIDE OF INTENSIVE CARE UNIT
por: Wahab, Abdul, et al.
Publicado: (2023)

IDENTIFICATION AND CLINICAL VALIDATION OF HYPOXIA-INDUCIBLE FACTOR 1α PROTEIN AS THE POTENTIAL BIOMARKER IN PATIENTS WITH SEPSIS
por: Ruan, Hang, et al.
Publicado: (2023)

Evidence‐based rationale for low dose nivolumab in critically ill patients with sepsis‐induced immunosuppression
por: van den Haak, Demy A. C., et al.
Publicado: (2023)

LACTATE IMPAIRS VASCULAR PERMEABILITY BY INHIBITING HSPA12B EXPRESSION VIA GPR81-DEPENDENT SIGNALING IN SEPSIS
por: Fan, Min, et al.
Publicado: (2022)

SEPSIS LEADS TO IMPAIRED MITOCHONDRIAL CALCIUM UPTAKE AND SKELETAL MUSCLE WEAKNESS BY REDUCING THE MICU1:MCU PROTEIN RATIO
por: Li, Xuexin, et al.
Publicado: (2023)

Association of Sex With Clinical Outcome in Critically Ill Sepsis Patients: A Retrospective Analysis of the Large Clinical Database MIMIC-III
por: Xu, Jinghong, et al.
Publicado: (2019)

Elevated Plasma Levels of Matrix Metalloproteinase-3 and Tissue-Inhibitor of Matrix Metalloproteinases-1 Associate With Organ Dysfunction and Mortality in Sepsis
por: Jones, Tiffanie K., et al.
Publicado: (2022)

Mesenchymal Stem/Stromal Cells Increase Cardiac miR-187-3p Expression in a Polymicrobial Animal Model of Sepsis
por: Ektesabi, Amin M., et al.
Publicado: (2021)

Simultaneous pharmacokinetic/pharmacodynamic (PKPD) assessment of ampicillin and gentamicin in the treatment of neonatal sepsis
por: Gastine, Silke, et al.
Publicado: (2021)

Noninvasive Imaging of Stored Red Blood Cell-Transfusion Aggravating Sepsis-Induced Liver Injury Associated with Increased Activation of M1-Polarized Kupffer Cells
por: Wu, Tao, et al.
Publicado: (2017)

Autophagy-Related IRGM Polymorphism Is Associated with Mortality of Patients with Severe Sepsis
por: Kimura, Tomonori, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1d912raai9jiol2mmbph72itiu